Latin America News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America News Network.

Press releases published on June 1, 2026

Jun. 1, 2026

Crumbs from the System: The U.S. "UFO Disclosure" Is a Joke Compared to What Dakila Has Already Proven

Indeterminate GlobeNewswire

Jun. 1, 2026

AMAX Accelerates AI Factory Performance with New Intel Xeon 6+ Processors

Indeterminate EIN Presswire

Jun. 1, 2026

Oncolytics Biotech® Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches

Indeterminate GlobeNewswire

Jun. 1, 2026

AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones

Indeterminate GlobeNewswire

Jun. 1, 2026

LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors

Indeterminate GlobeNewswire

Jun. 1, 2026

Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Indeterminate GlobeNewswire

Jun. 1, 2026

JET.AI ANNOUNCES LEADING INDEPENDENT PROXY ADVISORY FIRM GLASS LEWIS RECOMMENDS STOCKHOLDERS VOTE “FOR” THE PROPOSED MERGER

Indeterminate GlobeNewswire

Jun. 1, 2026

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

Indeterminate GlobeNewswire

Jun. 1, 2026

Ticketplus Files Registration Statement with the U.S. Securities and Exchange Commission (SEC) for Proposed Initial Public Offering

Indeterminate GlobeNewswire

Jun. 1, 2026

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Indeterminate GlobeNewswire

Jun. 1, 2026

Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders

Indeterminate GlobeNewswire

Jun. 1, 2026

K2 Group releases its 2025 Sustainability Report

Indeterminate EIN Presswire

Jun. 1, 2026

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Indeterminate GlobeNewswire

Jun. 1, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors

Indeterminate GlobeNewswire

Jun. 1, 2026

ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York

Indeterminate GlobeNewswire

Jun. 1, 2026

Ten-League International Holdings Limited Regains Compliance with Nasdaq Bid Price Requirement

Indeterminate GlobeNewswire

Jun. 1, 2026

Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026

Indeterminate GlobeNewswire